Marco Cerrano

Turin, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications

Favorable outcomes after early allogeneic stem cell transplantation in adult early T-cell precursor acute lymphoblastic leukemia treated with the pediatric-inspired GIMEMA LAL1913 program. A Campus ALL study.

Favorable outcomes after early allogeneic stem cell transplantation in adult early T-cell precursor acute lymphoblastic leukemia treated with the pediatric-inspired GIMEMA LAL1913 program. A Campus ALL study.

Journal: Bone marrow transplantation
Published: May 27, 2026

T-cell acute lymphoblastic leukemia in adults: current treatment approaches and future perspectives.

T-cell acute lymphoblastic leukemia in adults: current treatment approaches and future perspectives.

Journal: Expert review of hematology
Published: May 21, 2026

Infections and CAR-T cells for the treatment of lymphoid malignancies: a narrative review.

Infections and CAR-T cells for the treatment of lymphoid malignancies: a narrative review.

Journal: Frontiers in medicine
Published: March 13, 2026

Long-term safety and efficacy of ponatinib in intolerant chronic myeloid leukemia: subanalysis of the observational study of Iclusig® (ponatinib) treatment in patients with chronic myeloid leukemia in Italy.

Long-term safety and efficacy of ponatinib in intolerant chronic myeloid leukemia: subanalysis of the observational study of Iclusig® (ponatinib) treatment in patients with chronic myeloid leukemia in Italy.

Journal: Haematologica
Published: January 23, 2026

Case of brexu-cel at first relapse in an elderly patient

Case of brexu-cel at first relapse in an elderly patient

Journal: Recenti progressi in medicina
Published: January 22, 2026

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Journal: Blood
Published: August 29, 2025

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Journal: Blood
Published: August 29, 2025

Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia.

Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia.

Journal: Leukemia
Published: August 26, 2025

Mechanisms of Resistance to CAR T-Cells and How to Overcome Them.

Mechanisms of Resistance to CAR T-Cells and How to Overcome Them.

Journal: Methods and protocols
Published: July 27, 2025

Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic Neoplasm.

Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic Neoplasm.

Journal: Cancers
Published: July 16, 2025

Real-life management of 476 older adults with Philadelphia-negative acute lymphoblastic leukemia: a Campus ALL study.

Real-life management of 476 older adults with Philadelphia-negative acute lymphoblastic leukemia: a Campus ALL study.

Journal: Haematologica
Published: June 25, 2025

Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.

Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.

Journal: Annals of hematology
Published: May 30, 2025
Showing 1-12 of 87

Last Updated: 09/26/2026